By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Courtagen Life Sciences has raised $8 million in equity funding, the company disclosed in a regulatory filing on Friday.

The document filed with the US Securities Exchange Commission did not reveal how the funds will be used or who the participants in the round were but said that there were 67 investors.

A company spokesperson did not respond to a request for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.